A multicenter observational study of TAS-102 and regorafenib in patients with metastatic colorectal cancer
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Regorafenib (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 27 May 2016 New trial record